Protein haptenation by amoxicillin: High resolution mass spectrometry analysis and identification of target proteins in serum

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 504-520

  Ariza, Adriana ^a,b   Garzon, Davide ^c   Abánades, Daniel R ^a,b   de los Ríos, Vivian ^a   Vistoli, Giulio ^c   Torres, María J ^b   Carini, Marina ^c   Aldini, Giancarlo ^c   Pérez Sala, Dolores ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Lactam antibiotics; Amoxicillin binding; Amoxicillin targets; Drug allergy; High resolution mass spectrometry; Protein haptenation

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; HAPTEN; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PEPTIDE; TRANSFERRIN;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL PARAMETERS; MALE; MASS SPECTROMETRY; MOLECULAR MODEL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PROTEIN MODIFICATION; WESTERN BLOTTING;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BLOOD PROTEINS; DRUG HYPERSENSITIVITY; HAPTENS; HUMANS; MALE; MASS SPECTROMETRY;

EID: 84870390940     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.09.030     Document Type: Article

References (32)

1. Ariza A., Montañez M.I., Pérez-Sala D. Proteomics in immunological reactions to drugs. Curr Opin Allergy Clin Immunol 2011, 11:305-312.
2. Yvon M., Anglade P., Wal J.M. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule. FEBS Lett 1990, 263:237-240.
3. Yvon M., Wal J.M. Identification of lysine residue 199 of human serum albumin as a binding site for benzylpenicilloyl groups. FEBS Lett 1988, 239:237-240.
4. Meng X., Jenkins R.E., Berry N.G., Maggs J.L., Farrell J., Lane C.S., et al. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol Exp Ther 2011, 338:841-849.
5. Jenkins R.E., Meng X., Elliott V.L., Kitteringham N.R., Pirmohamed M., Park B.K. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin Appl 2009, 3:720-729.
6. Whitaker P., Meng X., Lavergne S.N., El-Ghaiesh S., Monshi M., Earnshaw C., et al. Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis. J Immunol 2011, 187:200-211.
7. Acton Q.A. Aminopenicillins: advances in research and application 2012, Scholarly Editions, Atlanta, USA.
8. Zhao Z., Batley M., D'Ambrosio C., Baldo B.A. In vitro reactivity of penicilloyl and penicillanyl albumin and polylysine conjugates with IgE-antibody. J Immunol Methods 2000, 242:43-51.
9. Audicana M., Bernaola G., Urrutia I., Echechipia S., Gastaminza G., Munoz D., et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin. Allergy 1994, 49:108-113.
10. Mayorga C., Obispo T., Jimeno L., Blanca M., Moscoso del Prado J., Carreira J., et al. Epitope mapping of beta-lactam antibiotics with the use of monoclonal antibodies. Toxicology 1995, 97:225-234.
11. Fujiwara K., Shin M., Miyazaki T., Maruta Y. Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats. Antimicrob Agents Chemother 2011, 55:62-71.
12. Hoizey G., Lamiable D., Frances C., Trenque T., Kaltenbach M., Denis J., et al. Simultaneous determination of amoxicillin and clavulanic acid in human plasma by HPLC with UV detection. J Pharm Biomed Anal 2002, 30:661-666.
13. Serrano J.M., Hita J., Ponferrada C.J., López M.C., Cárceles C.M. Intravenous pharmacokinetics and binding to plasmatic proteins of amoxycillin and clavulanic acid in sheeps. An Vet 1989, 5:75-87.
14. Makarov A., Denisov E., Kholomeev A., Balschun W., Lange O., Strupat K., et al. Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal Chem 2006, 78:2113-2120.
15. Perry R.H., Cooks R.G., Noll R.J. Orbitrap mass spectrometry: instrumentation, ion motion and applications. Mass Spectrom Rev 2008, 27:661-699.
16. Aldini G., Gamberoni L., Orioli M., Beretta G., Regazzoni L., Maffei Facino R., et al. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J Mass Spectrom 2006, 41:1149-1161.
17. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
18. Zhang Z., Marshall A.G. A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra. J Am Soc Mass Spectrom 1998, 9:225-233.
19. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5A resolution. Protein Eng 1999, 12:439-446.
20. Pedretti A., Villa L., Vistoli G. VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model 2002, 21:47-49.
21. Olsson M.H.M., Sondergard C.R., Rostkowski M., Jensen J.H. PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J Chem Theory Comput 2011, 7:525-537.
22. Morris G., Goodsell D., Halliday R., Huey R., Hart W., Belew R., et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998, 19:1639-1662.
23. Llinas A., Page M. Intramolecular general acid catalysis in the aminolysis of beta-lactam antibiotics. Org Biomol Chem 2004, 2:651-654.
24. Llinas A., Vilanova B., Page M. Thiol-catalysed hydrolysis of cephalosporins and possible rate-limiting amine anion expulsion. J Phys Org Chem 2004, 17:521-528.
25. Carey M.A., van Pelt F.N.A.M. Immunochemical detection of flucloxacillin adduct formation in livers of treated rats. Toxicology 2005, 216:41-48.
26. Magi B., Marzocchi B., Bini L., Cellesi C., Rossolini A., Pallini V. Two-dimensional electrophoresis of human serum proteins modified by ampicillin during therapeutic treatment. Electrophoresis 1995, 16:1190-1192.
27. Montáñez M.I., Nájera F., Pérez-Inestrosa E. NMR studies and molecular dynamic simulation of synthetic dendrimeric-antigens. Polymers 2011, 3:1533-1553.
28. Lavergne S.N., Wang H., Callan H.E., Park B.K., Naisbitt D.J. "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells. J Pharmacol Exp Ther 2009, 331:372-381.
29. Aldini G., Vistoli G., Regazzoni L., Gamberoni L., Facino R.M., Yamaguchi S., et al. Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species?. Chem Res Toxicol 2008, 21:824-835.
30. Yamaguchi S., Aldini G., Ito S., Morishita N., Shibata T., Vistoli G., et al. Delta(12)-prostaglandin J(2) as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. J Am Chem Soc 2010, 132:824-832.
31. Oettl K., Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 2007, 151:580-590.
32. Kormoczi G.F., Wolfel U.M., Rosenkranz A.R., Horl W.H., Oberbauer R., Zlabinger G.J. Serum proteins modified by neutrophil-derived oxidants as mediators of neutrophil stimulation. J Immunol 2001, 167:451-460.